21129605

Source:http://linkedlifedata.com/resource/pubmed/id/21129605

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013227, umls-concept:C0087111, umls-concept:C0740457
pubmed:dateCreated	2010-12-6
pubmed:abstractText	Over the last few years, targeted agents have assumed a predominant role in treatment of metastatic renal cell carcinoma (mRCC). Our aim is to discuss recent developments on this rapidly evolving topic.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7502030
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Benzenesulfonates, http://linkedlifedata.com/resource/pubmed/chemical/Interferons, http://linkedlifedata.com/resource/pubmed/chemical/MTOR protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/TOR Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab, http://linkedlifedata.com/resource/pubmed/chemical/everolimus, http://linkedlifedata.com/resource/pubmed/chemical/pazopanib, http://linkedlifedata.com/resource/pubmed/chemical/sorafenib, http://linkedlifedata.com/resource/pubmed/chemical/temsirolimus
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1532-1967
pubmed:author	pubmed-author:BigliettoMM, pubmed-author:BuonerbaCC, pubmed-author:CartenìGG, pubmed-author:ChiurazziBB, pubmed-author:Di LorenzoGG, pubmed-author:RiccardiFF, pubmed-author:ScognamiglioFF
pubmed:copyrightInfo	Copyright © 2010 Elsevier Ltd. All rights reserved.
pubmed:issnType	Electronic
pubmed:volume	36 Suppl 3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	S16-20
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:21129605-Antibodies, Monoclonal, pubmed-meshheading:21129605-Antibodies, Monoclonal, Humanized, pubmed-meshheading:21129605-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21129605-Benzenesulfonates, pubmed-meshheading:21129605-Carcinoma, Renal Cell, pubmed-meshheading:21129605-Disease-Free Survival, pubmed-meshheading:21129605-Humans, pubmed-meshheading:21129605-Immunotherapy, pubmed-meshheading:21129605-Interferons, pubmed-meshheading:21129605-Kidney Neoplasms, pubmed-meshheading:21129605-Prognosis, pubmed-meshheading:21129605-Pyridines, pubmed-meshheading:21129605-Pyrimidines, pubmed-meshheading:21129605-Sirolimus, pubmed-meshheading:21129605-Sulfonamides, pubmed-meshheading:21129605-TOR Serine-Threonine Kinases, pubmed-meshheading:21129605-Tumor Markers, Biological
pubmed:year	2010
pubmed:articleTitle	The therapy of kidney cancer with biomolecular drugs.
pubmed:affiliation	UOC Oncologia, Ospedale Cardarelli, Via A. Cardarelli, Naples, Italy.
pubmed:publicationType	Journal Article, Review